Intrinsiqq
Biocorrx Inc. logo

Biocorrx Inc. Quality Score

BICX

Compare
Quality30

Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
0/100
-2.0x

Negative earnings, no valuation support

Cash Flow Multiple
0/100
-3.2x

Negative FCF, no valuation support

Revenue Growth
100/100
25.6%

Above 10% CAGR, strong compounder

Cash Flow Growth
0/100
Negative FCF

FCF negative, burning cash after capex

Business Quality & Capital Allocation

Share Dilution
0/100
1978.9%

Heavy dilution above 5%

Margin Trend
100/100
+1345.1pp

Expanded 3+pp, strong improvement

Capital Structure
0/100
$258850

Positive debt with no FCF to service it

2022
$68615
$181328
2023
$65222
$1.00M
2024
$88033
$2.00M
2025
$139360
$1.00M
TTM
$18233
$277083
CashDebt
Return on Capital
0/100
-314.5%

Below 8%, may not cover cost of capital

Customize WeightsPremiumUpgrade

Biocorrx (BICX) quality: score, margins and returns

Biocorrx (BICX) scores 30/100 on Intrinsiqq's quality score (a lower-quality business), a weighted blend of 6 metrics each scored 0 to 100, on -851.8% operating margins and -314.5% ROIC. Every metric is computed from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Biocorrx (BICX) a high-quality business?+

Biocorrx scores 30 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which rates it a lower-quality business on these measures. Recent figures include a -851.8% operating margin and a -314.5% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Biocorrx's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from BICX's SEC filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Biocorrx scores well and where it falls behind.

What is Biocorrx's return on invested capital (ROIC)?+

Biocorrx earns about -314.5% on its invested capital, which is weak. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to BICX's margins and growth on this scorecard to judge durability.

How profitable is Biocorrx?+

Biocorrx runs an operating margin of about -851.8% and a net margin of about -584.4%. Revenue has grown at roughly 45.4% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from SEC filings, not investment advice.

How the market compares: US profitability statistics

SourceQuality score computed from the 10-Q filed 16 Nov 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 16 Nov 2026. How this is calculated.

Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Services-Specialty Outpatient Facilities, NEC · Pick stocks to compare with BICX

CompareIntrinsic value
BACKImac Holdings Inc.
$0.00+0.00%0
EHSIElite Health Systems Inc
$0.70-6.67%10
BRTXBiorestorative Therapies Inc.
$1.05-19.92%40
MGRXMangoceuticals, Inc.
$0.12-7.46%40
IMTHAnTix Holdings, Inc.
$0.00+0.00%25
EDGMEdgemode Inc.
$0.00+0.00%10
ADVBAdvanced Biomed Inc.
$1.65-5.71%20
ACONAclarion Inc.
$1.22-13.94%25

Spot a number that looks wrong? Check it in BICX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing BICX

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.